All cases were evaluated for efficacy using the HCC-modified Response Evaluation Criteria in Solid Tumors every 2–3 cycles after the treatment and serial tracking of alpha-fetoprotein (AFP) levels. Here, AFP is linked to hepatocellular carcinoma.